Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Joanna Baxter

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|January 9, 2013
Methods for detecting mutations in the human JAK2 geneAnthony J Bench, E Joanna Baxter, Anthony R Green
Methods in Molecular Medicine|March 1, 2006
Methods for the detection of the JAK2 V617F mutation in human myeloproliferative disordersPeter J Campbell, Linda M Scott, E Joanna Baxter, et al.
Haematologica|July 5, 2006
Size matters: the prognostic implications of large and small deletions of the derivative 9 chromosome in chronic myeloid leukemiaNasios Fourouclas, Peter J Campbell, Anthony J Bench, et al.
Genomics|August 6, 2005
L3mbtl, the mouse orthologue of the imprinted L3MBTL, displays a complex pattern of alternative splicing and escapes genomic imprintingJuan Li, Anthony J Bench, Sandie Piltz, et al.
Cancer Research|October 20, 2004
p53-Binding protein 1 is fused to the platelet-derived growth factor receptor beta in a patient with a t(5;15)(q33;q22) and an imatinib-responsive eosinophilic myeloproliferative disorderFrancis H Grand, Sonja Burgstaller, Thomas Kühr, et al.
Blood|November 22, 2014
Nongenetic stochastic expansion of JAK2V617F-homozygous subclones in polycythemia vera?Anna L Godfrey, Jyoti Nangalia, E Joanna Baxter, et al.
Blood|December 31, 2002
Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disordersAnimesh Pardanani, Terra Reeder, Luis F Porrata, et al.
Human Molecular Genetics|May 25, 2002
The t(4;22)(q12;q11) in atypical chronic myeloid leukaemia fuses BCR to PDGFRAE Joanna Baxter, Andreas Hochhaus, Pascual Bolufer, et al.
Blood|October 6, 2005
The V617F JAK2 mutation is uncommon in cancers and in myeloid malignancies other than the classic myeloproliferative disordersLinda M Scott, Peter J Campbell, E Joanna Baxter, et al.
Blood|October 29, 2015
Integration of innate into adaptive immune responses in ZAP-70-positive chronic lymphocytic leukemiaMichaela Wagner, Madlen Oelsner, Andrew Moore, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Methods in Molecular Biology (Clifton, N.J.)|January 9, 2013
Methods for detecting mutations in the human JAK2 geneAnthony J Bench, E Joanna Baxter, Anthony R Green
Methods in Molecular Medicine|March 1, 2006
Methods for the detection of the JAK2 V617F mutation in human myeloproliferative disordersPeter J Campbell, Linda M Scott, E Joanna Baxter, et al.
Haematologica|July 5, 2006
Size matters: the prognostic implications of large and small deletions of the derivative 9 chromosome in chronic myeloid leukemiaNasios Fourouclas, Peter J Campbell, Anthony J Bench, et al.
Genomics|August 6, 2005
L3mbtl, the mouse orthologue of the imprinted L3MBTL, displays a complex pattern of alternative splicing and escapes genomic imprintingJuan Li, Anthony J Bench, Sandie Piltz, et al.
Cancer Research|October 20, 2004
p53-Binding protein 1 is fused to the platelet-derived growth factor receptor beta in a patient with a t(5;15)(q33;q22) and an imatinib-responsive eosinophilic myeloproliferative disorderFrancis H Grand, Sonja Burgstaller, Thomas Kühr, et al.
Blood|November 22, 2014
Nongenetic stochastic expansion of JAK2V617F-homozygous subclones in polycythemia vera?Anna L Godfrey, Jyoti Nangalia, E Joanna Baxter, et al.
Blood|December 31, 2002
Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disordersAnimesh Pardanani, Terra Reeder, Luis F Porrata, et al.
Human Molecular Genetics|May 25, 2002
The t(4;22)(q12;q11) in atypical chronic myeloid leukaemia fuses BCR to PDGFRAE Joanna Baxter, Andreas Hochhaus, Pascual Bolufer, et al.
Blood|October 6, 2005
The V617F JAK2 mutation is uncommon in cancers and in myeloid malignancies other than the classic myeloproliferative disordersLinda M Scott, Peter J Campbell, E Joanna Baxter, et al.
Blood|October 29, 2015
Integration of innate into adaptive immune responses in ZAP-70-positive chronic lymphocytic leukemiaMichaela Wagner, Madlen Oelsner, Andrew Moore, et al.
Pageof 4